Recent research has indicated that the blood thinner Pradaxa may significantly increase a person’s risk of experiencing cardiovascular problems, including a heart attack. Pradaxa (dabigatran etexilate mesylate) is an anticoagulant medication, also called a blood thinner, which garnered FDA approval in October 2010. Manufactured by Boehringer Ingelheim, Pradaxa is commonly prescribed to patients with non-valvular atrial fibrillation, in an effort to reduce their risk of blood clots and stroke associated with the condition. Unfortunately, patients who take Pradaxa to reduce this risk may actually expose themselves to other life-threatening side effects like heart attack, heart disease and internal bleeding. If you took Pradaxa and have since suffered from a heart attack, contact a qualified Pradaxa attorney, as you may be entitled to recovery for your injuries and medical bills.
A heart attack occurs when the flow of blood to a part of the heart is blocked for a long enough period of time that a portion of the heart muscle becomes damaged or dies. The most common symptom of a heart attack is chest pain, which can feel like bad indigestion, a tight band around the chest, squeezing or heavy pressure, or something heavy sitting on your chest. Other heart attack symptoms may include:
The first choice of treatment for a heart attack is typically an angioplasty, which is a procedure that opens narrowed or blocked blood vessels that supply blood to the heart. Usually a small mesh tube called a stent is placed at the same time in order to help prevent the artery from closing up again. After a heart attack, your chance of having another one is higher. How well a patient does after a heart attack depends on the damage done to the heart muscle and heart valves, and where that damage is located. Unfortunately, if the heart can no longer adequately pump blood to the rest of the body, heart failure may occur. Abnormal heart rhythms can also occur, and can be life-threatening.
In December 2011, the FDA issued a drug safety communication indicating that patients who take Pradaxa may be at risk of suffering from serious bleeding events, namely internal bleeding that can lead to death. According to the FDA, bleeding that may lead to serious or even fatal outcomes is a well-recognized complication of all anticoagulant therapies. However, while internal bleeding caused by other blood thinner medications like warfarin can be treated with vitamin K, there is currently no antidote for internal bleeding associated with direct thrombin inhibitors like Pradaxa.
Although the most significant danger posed by the blood thinner, Pradaxa, is the risk of life-threatening internal bleeding in patients, a new Pradaxa side effect study published in the Archives of Internal Medicine indicates that Pradaxa patients may also be at risk of experiencing serious cardiovascular side effects. In fact, researchers involved in the study found that Pradaxa patients have a 33% increased risk of suffering from a heart attack or severe symptoms of heart disease than patients taking another anticoagulant called warfarin.
The heart attack side effects allegedly linked to the blood thinner Pradaxa may be severe enough to outweigh any possible benefits of the anticoagulant medication for some patients. If you or a loved one has suffered from a heart attack and you believe Pradaxa to be the cause, contact a Pradaxa attorney to discuss your legal options. You may have grounds to file a Pradaxa lawsuit against Boehringer Ingelheim in order to pursue financial compensation for your injuries, medical expenses, and pain and suffering. Drug companies like Boehringer Ingelheim are expected to produce safe and effective medications, and should be held accountable for any adverse side effects sustained by consumers of their products. With the help of a qualified Pradaxa lawyer, you can collect the compensation you deserve and bring public attention to the potentially harmful nature of the blood thinner Pradaxa.